Their ongoing work designing and curating a knowledgebase of all genes, targeted agents and published evidence helps oncologists identify up front precisely what should be tested and for which patients. Trapelo allows oncologists to order such tests from their preferred labs, and then synthesizes the results into standardized, actionable reports. Treatment options are ranked according to levels of evidence, empowering oncologists to make faster, more informed choices with confidence. 

Trapelo's independent validation of appropriate use of molecular testing and targeted treatment selection can be made available to participating payors automatically, obviating the need for traditional prior authorization for labs and providers.